InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-26 | 2026-03-30 | Shirvan Mitchell | CSO and CDO | Sale | 22.8K | $1.36 | $31K | 27.9K | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Research and development (including $0 and $1,796 from related party, for the year ended December 31, 2025 and December 31, 2024, respectively) | $7.1M+22.8% | $5.8M+56.8% | $3.7M |
| General and administrative (including $134 and $2,972 from related party, for the years ended December 31, 2025 and December 31, 2024, respectively) | $4.5M-33.5% | $6.8M+594.3% | $973K |
| TOTAL OPERATING EXPENSES | $11.6M-7.5% | $12.6M+168.6% | $4.7M |
| OPERATING LOSS | $11.6M-7.5% | $12.6M+168.6% | $4.7M |
| Financial expenses (income), net (including $232 and $(1,249) from related party, for the years ended December 31, 2025 and December 31, 2024, respectively) | $277K-93.0% | $3.9M+897.0% | $395K |
| LOSS BEFORE INCOME TAX | $11.9M-27.9% | $16.5M+225.2% | $5.1M |
| INCOME TAX | $3K-70.0% | $10K-68.8% | $32K |
| NET LOSS FOR THE YEAR | $11.9M-27.9% | $16.5M+223.4% | $5.1M |
| Equity holders of the Company | $11.9M-27.6% | $16.4M+232.7% | $4.9M |
| Non-controlling interests | $0-100.0% | $76K-54.2% | $166K |
| LOSS PER ORDINARY SHARE, BASIC | $9K-97.7% | $395K+792.9% | $44K |
| LOSS PER ORDINARY SHARE, DILUTED | $9K-97.7% | $395K+792.9% | $44K |
| WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES OUTSTANDING USED IN COMPUTATION OF BASIC LOSS PER SHARE | $1.33B+3093.3% | $41.6M-62.7% | $111.7M |
| WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES OUTSTANDING USED IN COMPUTATION OF DILUTED LOSS PER SHARE | $1.33B+3093.3% | $41.6M-62.7% | $111.7M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Silexion Therapeutics announces 1-for-10 reverse share split
Silexion Therapeutics Announces 1-for-10 Reverse Share Split
Silexion Therapeutics GAAP EPS of -$0.85 beats by $0.44
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update